Skip to main content
. 2020 Nov 10;21:471. doi: 10.1186/s12882-020-02144-6

Table 1.

Characteristics of study participants

CKD
(n = 2677)
Non-CKD
(n = 26,456)
P valuea
Age (years) 53.4 (6.6) 50.4 (6.9) < 0.001
Height (cm) 161.6 (8.3) 157.3 (5.9) < 0.001
Weight (kg) 61.4 (12.4) 54.9 (9.7) < 0.001
Body mass index (kg/m2) 23.4 (4.0) 22.1 (3.7) < 0.001
Obesity 784 (29.3) 4885 (18.5) < 0.001
Smoking status
 Current 592 (22.1) 4810 (18.2) < 0.001
 Former 324 (12.1) 1776 (6.7)
 None 1761 (65.8) 19,870 (75.1)
Alcohol intake
 Everyday 601 (22.5) 4164 (15.7) < 0.001
 Sometimes 778 (29.1) 7932 (30.0)
 None 1298 (48.5) 14,360 (54.3)
Hypertension 984 (36.8) 7649 (28.9) < 0.001
Dyslipidemia 1357 (50.7) 10,803 (40.8) < 0.001
Diabetes 193 (7.2) 888 (3.4) < 0.001
Creatinine (mg/dl) 0.82 (0.80, 0.90) 0.60 (0.56, 0.69) < 0.001
eGFR (ml/min/1.73 m2) 56.5 (11.4) 81.4 (13.0) < 0.001
Proteinuria stage
 A1 2302 (86.0) 26,456 (100.0) < 0.001
 A2 334 (12.5) 0 (0.0)
 A3 41 (1.5) 0 (0.0)
ALT (U/L) 18 (14, 25) 15 (12, 20) < 0.001
AST/ALT ratio 1.21 (0.39) 1.30 (0.40) < 0.001
GGT (U/L) 23 (16, 39) 18 (14, 27) < 0.001

CKD Chronic kidney disease, eGFR Estimated glomerular filtration rate

ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT Gamma-glutamyltransferase

Values were mean (standard deviation), median (25th percentile, 75th percentile) or n (%)

aUnpaired t -test, wilcoxon’s rank-sum test or chi-squared test